Posted by Michael Wonder on 05 Apr 2022
Curium announces FDA approval of a generic version of DaTscan (Ioflupane I 123 injection) in the U.S.
5 April 2022 - Curium announced today that its generic version of DaTscan (Ioflupane I 123 injection) was approved on 30 March 2022 by the U.S. FDA.
Ioflupane I 123 Injection is a singlep hoton emission computed tomography brain imaging agent used to assist in the evaluation of adult patients with suspected Parkinsonian syndromes.
